Nasal swab screening for methicillin-resistant Staphylococcus aureus-How well does it perform? A cross-sectional study

Infection Control and Hospital Epidemiology

Volumn 33, Issue 8, 2012, Pages 803-808

  Matheson, Ann ^a   Christie, Peter ^b   Stari, Traiani ^c   Kavanagh, Kim ^c   Gould, Ian M ^d   Masterton, Robert ^e   Reilly, Jacqui S ^a,f  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d NHS GRAMPIAN   (United Kingdom)

^e NHS AYRSHIRE AND ARRAN   (United Kingdom)

^f GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY SWAB; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NOSE SMEAR; PERINEAL SWAB; PREVALENCE; SCREENING; THROAT CULTURE;

AGED; AGED, 80 AND OVER; AXILLA; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CROSS INFECTION; CROSS-SECTIONAL STUDIES; CULTURE MEDIA; FEMALE; HUMANS; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE; PERINEUM; PHARYNX; STAPHYLOCOCCAL INFECTIONS; WOUNDS, PENETRATING;

EID: 84863758474     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/666639     Document Type: Article

References (30)

1. Reilly J, Stewart S, Allardice GA, et al. Results from the Scottish National HAI Prevalence Survey. J Hosp Infect 2008;69:62-68.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karch-mer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36: 53-59.
3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-174.
4. Gould IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006;28:379-384.
5. Kang CI, Song JH, Chung DR, et al. Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 2010;61:299-306.
6. Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007;28:1290-1298.
7. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consulta-tion-a study of 521 patients in Germany. J Infect 2009;59: 232-239.
8. Weigelt JA, Lipsky BA, Tabak YP, Derby KG, Kim M, Gupta V. Surgical site infections: causative pathogens and associated outcomes. Am J Infect Control 2010;38:112-120.
9. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ 2005;331:992.
10. Reilly JS, Stewart S, Christie P, et al. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. J Hosp Infect 2012; 80:31-35.
11. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:281-285.
12. Health Protection Scotland on behalf of Pathfinder Health Boards. Final Report Volume 1: An Investigation of the Clinical Effectiveness of MRSA Screening. Glasgow: Health Protection Scotland, 2009. http://www.documents.hps.scot.nhs.uk/hai/mrsa-screening/pathfinder-programme/mrsa-pathfinder-vol1-2011-02-23.pdf. Accessed May 1, 2012.
13. Ritchie K, Craig J, Eastgate J, et al. The Clinical and Cost Effectiveness of Screening for Meticillin-Resistant Staphylococcus au-reus (MRSA). Edinburgh: National Health Service Quality Improvement Scotland, 2007.
14. Acton DS, Plat-Sinnige MJ, van Wamel W, de Groot N, van Bel-kum A. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact? Eur J Clin Microbiol Infect Dis 2009;28:115-127.
15. Bitterman Y, Laor A, Itzhaki S, Weber G. Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization. Eur J Clin Microbiol Infect Dis 2010;29:391-397.
16. Coello R, Glynn JR, Gaspar C, Picazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staph-ylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997;37:39-46.
17. Harbarth S, Schrenzel J, Renzi G, Akakpo C, Ricou B. Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol 2007;45:1072-1073.
18. Lautenbach E, Nachamkin I, Hu B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider-and patient-collected samples. Infect Control Hosp Epidemiol 2009;30:380-382.
19. Mermel LA, Eells SJ, Acharya MK, et al. Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylo-coccus aureus nasal colonization in different patient populations: a prospective, multicenter study. Infect Control Hosp Epidemiol 2010;31:592-597.
20. Meurman O, Routamaa M, Peltonen R. Screening for methi-cillin-resistant Staphylococcus aureus: which anatomical sites to culture? J Hosp Infect 2005;61:351-353.
21. Batra R, Eziefula AC, Wyncoll D, Edgeworth J. Throat and rectal swabs may have an important role in MRSA screening of critically ill patients. Intensive Care Med 2008;34:1703-1706.
22. Haley CC, Mittal D, Laviolette A, Jannapureddy S, Parvez N, Haley RW. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivariable risk factor screening to increase efficiency of surveillance culturing. J Clin Microbiol 2007;45:3031-3038.
23. Adults with Incapacity (Scotland) Act 2000. Edinburgh: Scottish Government, 2000.
24. Health Protection Scotland. NHS Scotland MRSA Screening Pathfinder Programme: Interim Report. Glasgow: Health Protection Scotland, 2009.
25. Grmek-Kosnik I, Ihan A, Dermota U, Rems M, Kosnik M, Jorn KH. Evaluation of separate vs pooled swab cultures, different media, broth enrichment and anatomical sites of screening for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. J Hosp Infect 2005;61:155-161.
26. Coello R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
27. Eveillard M, Leroy C, Teissiere F, et al. Impact of selective screening in the emergency department on meticillin-resistant Staph-ylococcus aureus control programmes. J Hosp Infect 2006;63: 380-384.
28. Lee BY, Bailey RR, Smith KJ, et al. Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 2010;31:598-606.
29. Health Protection Scotland. Discharge Testing for MRSA in Scottish Hospitals: MRSA Acquisition, Description of Acquired Strains and Risk Factors for Acquisition of MRSA in the Hospital. Glasgow: Health Protection Scotland, 2010. http://www.documents.hps.scot.nhs.uk/hai/mrsa-screening/pathfinder-programme/mrsa-pathfinder-discharge-2011-03-18.pdf. Accessed May 1, 2012.
30. Health Protection Scotland. NHS Scotland MRSA Screening Pathfinder Programme: The Value of Nasal Swabbing versus Full Body Screening or Clinical Risk Assessment to Detect MRSA Colonisation at Admission to Hospital. Glasgow: Health Protection Scotland, 2011. http://www.documents.hps.scot.nhs.uk/hai/mrsa-screening/pathfinder-programme/mrsa-pathfinder-admissions-2011-02-23.pdf. Accessed May 1, 2012.